Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.
Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Australia.
Clin J Am Soc Nephrol. 2024 May 1;19(5):641-649. doi: 10.2215/CJN.0000000000000280. Epub 2023 Aug 14.
Peritoneal dialysis (PD) represents an important treatment choice for patients with kidney failure. It allows them to dialyze outside the hospital setting, facilitating enhanced opportunities to participate in life-related activities, flexibility in schedules, time and cost savings from reduced travel to dialysis centers, and improved quality of life. Despite its numerous advantages, PD utilization has been static or diminishing in parts of the world. PD-related infection, such as peritonitis, exit-site infection, or tunnel infection, is a major concern for patients, caregivers, and health professionals-which may result in hesitation to consider this as treatment or to cease therapy when these complications take place. In this review, the definition, epidemiology, risk factors, prevention, and treatment of PD-related infection on the basis of the contemporary evidence will be described.
腹膜透析(PD)是肾衰竭患者的重要治疗选择。它可以让患者在医院以外的环境中进行透析,从而增加他们参与生活相关活动的机会,提高日程安排的灵活性,减少往返透析中心的旅行费用和时间,改善生活质量。尽管 PD 有很多优点,但在世界某些地区,PD 的应用率却一直保持不变甚至在下降。PD 相关感染,如腹膜炎、出口部位感染或隧道感染,是患者、护理人员和卫生专业人员关注的主要问题,这可能导致在考虑治疗方案时犹豫不决,或者在出现这些并发症时停止治疗。在本综述中,将根据现有证据描述 PD 相关感染的定义、流行病学、危险因素、预防和治疗。